Review
Early View Article
DOI DOI: 10.62063/rev-40

The effects of green tea and curcumin on COMT and MAO pathways in nutrigenetics-based epigenetic approaches: Clinical benefits and the balanced management of psycho-oncological risks

Gulsen Meral1, Elif Sibel Aslan2, Neval Burkay3, Merve Ozkaya3, Esma Gokcen Alper Acar3
  1. 1 Epigenetic Coaching, London, United Kingdom; İstanbul Nişantaşı Üniversitesi
  2. 2 Biruni University
  3. 3 Epigenetic Coaching, London, United Kingdom

Abstract

The worldwide prevalence of all cancer types continues to rise. In this context, the psychological burden of cancer—particularly anxiety and depression—has emerged as a critical yet frequently overlooked component of comprehensive oncological care. In addition to clinical and psychosocial factors, growing evidence suggests that epigenetic mechanisms significantly influence both cancer biology and mental health, indicating that gene-environment interactions may affect psychological vulnerability in oncology contexts. Nutrigenetics-based epigenetic approaches enable personalized dietary and nutraceutical interventions based on individual genetic variability. Green tea catechins and curcumin are widely used bioactive compounds due to their epigenetic and anticancer potential. However, by altering the activity of catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO), important enzymes that degrade dopamine, norepinephrine, and serotonin, these substances have an impact on monoaminergic neurotransmission. Functional polymorphisms in the COMT and MAO genes may lead to substantial interindividual differences in mood regulation, stress responsiveness, and anxiety susceptibility. This review addresses molecular, clinical, and psycho-oncological aspects of the effects of green tea and curcumin on COMT and MAO pathways within a nutrigenetics-based epigenetic nutrition framework. The findings emphasize that the potential clinical benefits of epigenetically active nutraceuticals should be evaluated through a genotype-guided, individualized, and balanced approach.

How to Cite

Meral, G., Aslan, E. S., Burkay, N., Ozkaya, M., & Alper Acar, E. G. (2026). The effects of green tea and curcumin on COMT and MAO pathways in nutrigenetics-based epigenetic approaches: Clinical benefits and the balanced management of psycho-oncological risks. EUCHEMBIOJ Reviews, 2(1), e26005. https://doi.org/10.62063/rev-40
Endnote/Zotero/Mendeley (RIS) BibTeX

References

  1. Abdul, Q. A., Yu, B. P., Chung, H. Y., Jung, H. A., & Choi, J. S. (2017). Epigenetic modifications of gene expression by lifestyle and environment. Archives of Pharmacal Research, 40(11), 1219–1237. https://doi.org/10.1007/s12272-017-0973-3
  2. Afzal, M., Safer, A. M., & Menon, M. (2015). Green tea polyphenols and their potential role in health and disease. Inflammopharmacology, 23(4), 151–161. https://doi.org/10.1007/s10787-015-0236-1
  3. Antypa, N., Drago, A., & Serretti, A. (2013). The role of COMT gene variants in depression: Bridging neuropsychological, behavioral and clinical phenotypes. Neuroscience & Biobehavioral Reviews, 37(8), 1597–1610. https://doi.org/10.1016/j.neubiorev.2013.06.006
  4. Aronica, L., Ordovas, J. M., Volkov, A., Lamb, J. J., Stone, P. M., Minich, D., Leary, M., Class, M., Metti, D., Larson, I. A., Contractor, N., Eck, B., & Bland, J. S. (2022). Genetic biomarkers of metabolic detoxification for personalized lifestyle medicine. Nutrients, 14(4), Article 768. https://doi.org/10.3390/nu14040768
  5. Bakrim, S., El Omari, N., El Yaagoubi, O. M., Khalid, A., Abdalla, A. N., Hamza, S. M. A., Ibrahim, S. E., Atifi, F., Zaid, Y., Bouyahya, A., El Fessikh, M., Ming, L. C., & Aanniz, T. (2025). Epi-nutrients for cancer prevention: Molecular mechanisms and emerging insights. Cell Biology and Toxicology, 41(1), Article 116. https://doi.org/10.1007/s10565-025-10054-2
  6. Bastos, P., Gomes, T., & Ribeiro, L. (2017). Catechol-O-methyltransferase (COMT): An update on its role in cancer, neurological and cardiovascular diseases. Reviews of Physiology, Biochemistry and Pharmacology, 173, 1–39. https://doi.org/10.1007/112_2017_2
  7. Bordoni, L., & Gabbianelli, R. (2019). Primers on nutrigenetics and nutri(epi)genomics: Origins and development of precision nutrition. Biochimie, 160, 156–171. https://doi.org/10.1016/j.biochi.2019.03.006
  8. Carlos-Reyes, Á., López-González, J. S., Meneses-Flores, M., Gallardo-Rincón, D., Ruíz-García, E., Marchat, L. A., Astudillo-de la Vega, H., Hernández de la Cruz, O. N., & López-Camarillo, C. (2019). Dietary compounds as epigenetic modulating agents in cancer. Frontiers in Genetics, 10, Article 79. https://doi.org/10.3389/fgene.2019.00079
  9. Carlson, L. E., Ismaila, N., Addington, E. L., Asher, G. N., Atreya, C., Balneaves, L. G., Bradt, J., Fuller-Shavel, N., Goodman, J., Hoffman, C. J., Huston, A., Mehta, A., Paller, C. J., Richardson, K., Seely, D., Siwik, C. J., Temel, J. S., & Rowland, J. H. (2023). Integrative oncology care of symptoms of anxiety and depression in adults with cancer: Society for Integrative Oncology–ASCO guideline. Journal of Clinical Oncology, 41(28), 4562–4591. https://doi.org/10.1200/jco.23.00857
  10. Chaurasiya, N. D., Leon, F., Muhammad, I., & Tekwani, B. L. (2022). Natural products inhibitors of monoamine oxidases: Potential new drug leads for neuroprotection, neurological disorders, and neuroblastoma. Molecules, 27(13), Article 4297. https://doi.org/10.3390/molecules27134297
  11. Chen, D., Wang, C. Y., Lambert, J. D., Ai, N., Welsh, W. J., & Yang, C. S. (2005). Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: Structure–activity relationship and molecular-modeling studies. Biochemical Pharmacology, 69(10), 1523–1531. https://doi.org/10.1016/j.bcp.2005.01.024
  12. Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., Egan, M. F., Kleinman, J. E., & Weinberger, D. R. (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics, 75(5), 807–821. https://doi.org/10.1086/425589
  13. Çamlıca, T., & Eti Aslan, F. (2022). Sağlıkta “4P tıbbı”: Geleneksel tıp tarih mi oluyor? Sağlık Akademisyenleri Dergisi, 9(4), 382–387. https://doi.org/10.52880/sagakaderg.1132907
  14. Edmondson, D. E., Mattevi, A., Binda, C., Li, M., & Hubálek, F. (2005). Structure and mechanism of monoamine oxidase. In Burger's Medicinal Chemistry and Drug Discovery. https://doi.org/10.1002/0471266949.bmc111
  15. Ginsburg, G. S., & Phillips, K. A. (2018). Precision medicine: From science to value. Health Affairs, 37(5), 694–701. https://doi.org/10.1377/hlthaff.2017.1624
  16. Giraldi, T., De Vanna, M., Malagoli, M., Tuveri, G., Sutto, K., Schillani, G., & Grassi, L. (2007). Mental adaptation to cancer: Depression and blood platelet monoamine oxidase activity in breast cancer patients. Anticancer Research, 27(3B), 1715–1719.
  17. Grassi, L., Caruso, R., Riba, M. B., Lloyd-Williams, M., Kissane, D., Rodin, G., McFarland, D., Campos-Ródenas, R., Zachariae, R., Santini, D., & Ripamonti, C. I. (2023). Anxiety and depression in adult cancer patients: ESMO clinical practice guideline. ESMO Open, 8(2), Article 101155. https://doi.org/10.1016/j.esmoop.2023.101155
  18. Hajj, A., Hachem, R., Khoury, R., Hallit, S., El B., J., Nasr, F., El Karak, F., Chahine, G., Kattan, J., & Rabbaa Khabbaz, L. (2021). Clinical and genetic factors associated with anxiety and depression in breast cancer patients: A cross-sectional study. BMC Cancer, 21(1), Article 872. https://doi.org/10.1186/s12885-021-08615-9
  19. Harrison, P. J., & Tunbridge, E. M. (2008). Catechol-O-methyltransferase (COMT): A gene contributing to sex differences in brain function and to sexual dimorphism in psychiatric disorders. Neuropsychopharmacology, 33(13), 3037–3045. https://doi.org/10.1038/sj.npp.1301543
  20. Hassan, F. U., Rehman, M. S., Khan, M. S., Ali, M. A., Javed, A., Nawaz, A., & Yang, C. (2019). Curcumin as an alternative epigenetic modulator: Mechanism of action and potential effects. Frontiers in Genetics, 10, Article 514. https://doi.org/10.3389/fgene.2019.00514
  21. Henning, S. M., Wang, P., Carpenter, C. L., & Heber, D. (2013). Epigenetic effects of green tea polyphenols in cancer. Epigenomics, 5(6), 729–741. https://doi.org/10.2217/epi.13.57
  22. Khatri, D. K., & Juvekar, A. R. (2016). Kinetics of inhibition of monoamine oxidase using curcumin and ellagic acid. Pharmacognosy Magazine, 12(Suppl 2), S116–S120. https://doi.org/10.4103/0973-1296.182168
  23. Koç, G. (2018). Nutrigenomik: Genotipten fenotipe beslenme etkisi. Tıp Fakültesi Klinikleri Dergisi, 1(1), 79–92.
  24. Kumar, P., & Rai, V. (2020). Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: A meta-analysis. Metabolic Brain Disease, 35(2), 241–251. https://doi.org/10.1007/s11011-019-00495-0
  25. Kwon, H. J., Jin, H. J., & Lim, M. H. (2014). Association between monoamine oxidase gene polymorphisms and attention deficit hyperactivity disorder in Korean children. Genetic Testing and Molecular Biomarkers, 18(7), 505–509. https://doi.org/10.1089/gtmb.2014.0066
  26. Lu, H., Meng, X., & Yang, C. S. (2003). Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (−)-epigallocatechin gallate. Drug Metabolism and Disposition, 31(5), 572–579. https://doi.org/10.1124/dmd.31.5.572
  27. Meeran, S. M., Ahmed, A., & Tollefsbol, T. O. (2010). Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clinical Epigenetics, 1(3), 101–116. https://doi.org/10.1007/s13148-010-0011-5
  28. Meral, G., Aslan, E. S., Burkay, N., Alper Acar, E. G., Karagöz, M. F., Özkaya, M., Sahin, E., & Alp, M. Y. (2024). Importance of using epigenetic nutrition and supplements based on nutrigenetic tests in personalized medicine. Cureus, 16(8), e66959. https://doi.org/10.7759/cureus.66959
  29. Mir, R., Bhat, M., Javid, J., Jha, C., Saxena, A., & Banu, S. (2018). Potential impact of COMT-rs4680 G > A gene polymorphism in coronary artery disease. Journal of Cardiovascular Development and Disease, 5(3), Article 38. https://doi.org/10.3390/jcdd5030038
  30. Naoi, M., Wu, Y., Maruyama, W., & Shamoto-Nagai, M. (2025). Phytochemicals modulate biosynthesis and function of serotonin, dopamine, and norepinephrine for treatment of monoamine neurotransmission-related psychiatric diseases. International Journal of Molecular Sciences, 26(7), Article 2916. https://doi.org/10.3390/ijms26072916
  31. Ramaholimihaso, T., Bouazzaoui, F., & Kaladjian, A. (2020). Curcumin in depression: Potential mechanisms of action and current evidence—A narrative review. Frontiers in Psychiatry, 11, Article 572533. https://doi.org/10.3389/fpsyt.2020.572533
  32. Reuter, S., Gupta, S. C., Park, B., Goel, A., & Aggarwal, B. B. (2011). Epigenetic changes induced by curcumin and other natural compounds. Genes & Nutrition, 6(2), 93–108. https://doi.org/10.1007/s12263-011-0222-1
  33. Rivest, J., Barclay, C. L., & Suchowersky, O. (1999). COMT inhibitors in Parkinson's disease. Canadian Journal of Neurological Sciences, 26(Suppl. 2), S34–S38. https://doi.org/10.1017/s031716710000007x
  34. Sarwar, S., & Hasnain, S. (2021). Association of variable number of tandem repeats (VNTR) and T941G polymorphism of monoamine oxidase (MAO-A) gene with aggression in Pakistani subjects. African Health Sciences, 21(1), 180–188. https://doi.org/10.4314/ahs.v21i1.24
  35. Shih, J. C., Chen, K., & Ridd, M. J. (1999). Monoamine oxidase: From genes to behavior. Annual Review of Neuroscience, 22, 197–217. https://doi.org/10.1146/annurev.neuro.22.1.197
  36. Singh, B. N., Shankar, S., & Srivastava, R. K. (2011). Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochemical Pharmacology, 82(12), 1807–1821. https://doi.org/10.1016/j.bcp.2011.07.093
  37. Tanifuji, T., Okazaki, S., Otsuka, I., Horai, T., Shinko, Y., Kim, S., Sora, I., & Hishimoto, A. (2021). Association of two variable number of tandem repeats in the monoamine oxidase A gene promoter with schizophrenia. Neuropsychiatric Disease and Treatment, 17, 3315–3323. https://doi.org/10.2147/NDT.S338854
  38. Teiten, M. H., Dicato, M., & Diederich, M. (2013). Curcumin as a regulator of epigenetic events. Molecular Nutrition & Food Research, 57(9), 1619–1629. https://doi.org/10.1002/mnfr.201300201
  39. Tekpınar, L., & Erdem, R. (2019). Kişiselleştirilmiş tıp ve genom araştırmalarının sağlık çıktıları bağlamında değerlendirilmesi. Hacettepe Sağlık İdaresi Dergisi, 22(4), 843–862.
  40. Toledo-Lozano, C. G., López-Hernández, L. B., Suárez-Cuenca, J. A., Villalobos-Gallegos, L., Jiménez-Hernández, D. A., Alcaraz-Estrada, S. L., Mondragón-Terán, P., Joya-Laureano, L., Coral-Vázquez, R. M., & García, S. (2023). Individual and combined effect of MAO-A/MAO-B gene variants and adverse childhood experiences on the severity of major depressive disorder. Behavioral Sciences, 13(10), Article 795. https://doi.org/10.3390/bs13100795
  41. Topaz, G. R., March, A., Smith, V. E., & Stieglitz, K. A. (2019). Inhibition of monoamine oxidase (MAO) via green tea extracts: Structural insights of catechins as potential inhibitors of MAO. In Frontiers in Natural Product Chemistry (Vol. 5, pp. 1–38). Bentham Science Publishers. https://doi.org/10.2174/9789811423772119050003
  42. Vrânceanu, M., Galimberti, D., Banc, R., Dragoş, O., Cozma-Petruţ, A., Hegheş, S. C., Voştinaru, O., Cuciureanu, M., Stroia, C. M., Miere, D., & Filip, L. (2022). The anticancer potential of plant-derived nutraceuticals via the modulation of gene expression. Plants, 11(19), Article 2524. https://doi.org/10.3390/plants11192524
  43. Witte, A. V., & Flöel, A. (2012). Effects of COMT polymorphisms on brain function and behavior in health and disease. Brain Research Bulletin, 88(5), 418–428. https://doi.org/10.1016/j.brainresbull.2011.11.012
  44. Yüce-Dursun, B. (2017). Çeşitli bitki çaylarının monoamin oksidaz inhibisyonlarının ve antioksidan etkilerinin belirlenmesi. Trakya University Journal of Natural Sciences, 18(2).